4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-002674
Options or other derivatives
- Chief Medical Officer acquired 1,052,028 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Amado Rafael Chief Medical Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +859,968 | 859,968 | D | ||
| Amado Rafael Chief Medical Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +192,060 | 192,060 | D | ||
Loading xslF345X03/a4.xml…